Showing results (261-270 of 312) with videos related to
Sort By:
Pageof 32
Current Biology : CB|December 7, 2021
Coordinated repression of pro-differentiation genes via P-bodies and transcription maintains Drosophila intestinal stem cell identityKasun Buddika, Yi-Ting Huang, Ishara S Ariyapala, et al.Genome Medicine|April 26, 2023
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancersKatherine E Hutchinson, Jessica W Chen, Heidi M Savage, et al.Gynecologic Oncology|January 9, 2022
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroupsDouglas I Lin, Alexander Fine, Natalie A Danziger, et al.JCO Precision Oncology|November 22, 2023
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency SignatureFelipe Batalini, Russell W Madison, Ethan S Sokol, et al.JCO Precision Oncology|August 8, 2024
Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable AlterationsHiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.Endocrine-Related Cancer|August 19, 2021
Targeted genomic analysis of 364 adrenocortical carcinomasNikita Pozdeyev, Lauren Fishbein, Laurie M Gay, et al.Cancer Research|June 8, 2026
Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer CellsEun Jung Kim, Dexter X Jin, Alejandro M Chibly, et al.JCO Precision Oncology|September 9, 2020
Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of HeterozygosityEthan S Sokol, Dean Pavlick, Hossein Khiabanian, et al.Proceedings of the National Academy of Sciences of the United States of America|July 31, 2020
An ErbB2 splice variant lacking exon 16 drives lung carcinomaHarvey W Smith, Lei Yang, Chen Ling, et al.Pageof 32